Evidence map›Paper›PMID 27593486›Full record

ArticleThe Journal of hand surgery2016

Erythropoietin Enhanced Recovery After Traumatic Nerve Injury: Myelination and Localized Effects.

Leigh Sundem, Kuang-Ching Chris Tseng, Haiyan Li, John Ketz, Mark Noble, John Elfar

Open access · greenAbstract readComparative Study
In one paragraph

Article in The Journal of hand surgery, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 39 citations in OpenAlex.

  1. Review
  2. Review
  3. Recombinant Erythropoietin Induces Oligodendrocyte Progenitor Cell Proliferation After Traumatic Brain Injury and Delayed Hypoxemia.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2023
    Article
  4. Article
  5. Article
  6. Article
  7. Peripheral Nerve Injury Treatments and Advances: One Health Perspective.International journal of molecular sciences · 2022
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Pharmacological Attenuation of Electrical Effects in a Model of Compression Neuropathy.The Journal of bone and joint surgery. American volume · 2019
    Article
  15. Article
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Leigh SundemCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY.
Kuang-Ching Chris TsengCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY.
Haiyan LiCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY.
John KetzDepartment of Orthopaedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY.
Mark NobleDepartment of Biomedical Genetics, Institute for Stem Cell and Regenerative Medicine, University of Rochester Medical Center, Rochester, NY.
John ElfarCenter for Musculoskeletal Research, University of Rochester Medical Center, Rochester, NY; Department of Orthopaedics and Rehabilitation, University of Rochester Medical Center, Rochester, NY. Electronic address: openelfar@gmail.com.
University of Rochester Medical Center · US

Funding

Erythropoietin for NeuroregenerationK08AR060164 · NIAMS · UNIVERSITY OF ROCHESTER · PI ELFAR, JOHN · 2013 to 2017
$578k
NIAMS NIH HHS K08 AR060164
6 · The paper itself

Abstract

purposeWe previously found that administration of erythropoietin (EPO) shortens the course of recovery after experimental crush injury to the mouse sciatic nerve. The course of recovery was more rapid than would be expected if EPO's effects were caused by axonal regeneration, which raised the question of whether recovery was instead the result of promoting remyelination and/or preserving myelin on injured neurons. This study tested the hypothesis that EPO has a direct and local effect on myelination in vivo and in vitro.

methodsAnimals were treated with EPO after standard calibrated sciatic nerve crush injury; immunohistochemical analysis was performed to assay for myelinated axons. Combined in vitro neuron-Schwann cell co-cultures were performed to assess EPO-mediated effects directly on myelination and putative protective effects against oxidative stress. In vivo local administration of EPO in a fibrin glue carrier was used to demonstrate early local effects of EPO treatment well in advance of possible neuroregenerative effects.

resultsSystemic Administration of EPO maintained more in vivo myelinated axons at the site of nerve crush injury. In vitro, EPO treatment promoted myelin formation and protected myelin from the effects of nitric oxide exposure in co-cultures of Schwann cells and dorsal root ganglion neurons. In a novel, surgically applicable local treatment using Food and Drug Administration-approved fibrin glue as a vehicle, EPO was as effective as systemic EPO administration at time points earlier than those explainable using standard models of neuroregeneration.

conclusionsIn nerve crush injury, EPO may be exerting a primary influence on myelin status to promote functional recovery. CLINICAL RELEVANCE: Mixed injury to myelin and axons may allow the opportunity for the repurposing of EPO for use as a myeloprotective agent in which injuries spare a requisite number of axons to allow early functional recovery.

Indexed as

AnimalsBiopsy, NeedleCrush InjuriesDisease Models, AnimalErythropoietinFemaleImmunohistochemistryInfusions, ParenteralInjections, IntralesionalMiceMice, Inbred C57BLMyelin SheathNerve RegenerationRandom AllocationRecovery of FunctionSciatic NerveErythropoietinErythropoietinfunctional recoveryperipheral nerve injuryregeneration

Identifiers

PMID27593486
PMCPMC5053901
OpenAlexW2517654257

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.